Introduction to Semax Bulk Powder for Research
Semax is a synthetic heptapeptide widely utilised in neuroscience research, consisting of the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro. Derived from the adrenocorticotropic hormone (ACTH) fragment 4–10, Semax has attracted significant attention for its potential modulatory effects on neurotrophic factors and neurotransmitter systems without crossing into therapeutic application. For laboratories requiring reproducible results and cost-effective sourcing, Semax bulk powder for research provides a lyophilised form that maintains long-term stability under controlled conditions. Researchers studying synaptic plasticity, cognitive processes, and neuroprotection frequently incorporate this peptide into experimental protocols involving in vitro and in vivo models. The bulk powder format allows flexibility in reconstitution, enabling precise adjustment of concentration for diverse assay designs. This article details the chemical properties, research applications, handling requirements, and quality assurance measures essential for procurement officers and scientists evaluating Semax for their investigative pipelines.
Chemical and Physical Properties
Understanding the fundamental characteristics of Semax is critical for proper handling and experimental design. The peptide is identified by the CAS number 80714-61-0, with a molecular formula of C33H46N8O8 and a molecular weight of 682.77 g/mol. Commercial preparations intended for Semax bulk powder for research are typically supplied with a purity of ≥98%, as determined by high-performance liquid chromatography (HPLC). This level of purity minimises interference from truncated sequences or residual solvents, supporting data integrity. The lyophilised powder appears as a white to off-white amorphous solid, fully soluble in aqueous buffers once reconstituted. Because Semax is a synthetic peptide, it lacks the glycosylation or other post-translational modifications found in endogenous proteins, simplifying analytical verification.
Structure and Stability
The primary sequence Met-Glu-His-Phe-Pro-Gly-Pro imparts a high degree of conformational flexibility, with the proline residues inducing turns that may influence receptor interaction in experimental settings. Stability studies indicate that the lyophilised powder remains intact when stored at −20°C in a dry, dark environment. Exposure to ambient humidity or repeated freeze–thaw cycles can promote aggregation or oxidation of the methionine residue, potentially altering research outcomes. To preserve structural fidelity, laboratories should aliquot the reconstituted solution into single-use portions and avoid temperature fluctuations. Under these conditions, the peptide retains its physicochemical profile for up to two years, as confirmed by periodic HPLC and mass spectrometry re-testing.
Applications de la recherche
In experimental neuroscience, Semax is employed as a tool to investigate mechanisms of neuroprotection and cognitive modulation. Numerous published studies using rodent and cell-culture models have examined how Semax bulk powder for research influences brain-derived neurotrophic factor (BDNF) expression. Observed upregulation of BDNF in certain hippocampal regions provides a framework for probing neurotrophin signalling cascades. Beyond BDNF, Semax has been utilised in paradigms assessing learning, memory consolidation, and adaptive behaviour under stress. For example, in Morris water maze and passive avoidance tests, researchers have recorded performance changes following peptide administration, though results depend heavily on dose, timing, and model species. Such findings underscore the peptide’s utility as a neurochemical probe rather than any applied endpoint.
Neuroscience and Neuropharmacology
At the receptor level, laboratory investigations suggest that Semax may modulate dopamine and serotonin receptor activity in a context-dependent manner. Radioligand binding assays and electrophysiological recordings have provided data indicating shifts in neurotransmitter sensitivity, although full mechanistic elucidation remains ongoing. Studies also point to an influence on synaptic plasticity, with in vitro models showing altered long-term potentiation (LTP) following Semax exposure. This positions the peptide as a valuable reference compound for researchers exploring neurotrophic mechanisms and adaptive neural circuitry. Importantly, all such work is confined to preclinical models; Semax bulk powder for research is not approved for any diagnostic or clinical application.
Bulk Powder Specifications and Handling
The lyophilised format of Semax is engineered to withstand transport and extended storage without refrigeration during shipment, provided the powder is kept in sealed, moisture-proof vials containing desiccant. Upon receipt, it is imperative to transfer the product to −20°C storage immediately. For reconstitution, sterile distilled water, 0.9% saline, or phosphate-buffered saline is commonly used. The recommended practice is to prepare a stock solution at a concentration conducive to subsequent dilution into cell culture media or injection buffers, exacting volumes based on the required molarity for a given experiment. Because peptide content can vary slightly between batches, researchers should consult the Certificate of Analysis for net peptide weight and adjust calculations accordingly. Dedicated handling with sterile syringes and low-protein-binding consumables minimises adsorptive loss.
Storage and Stability Guidelines
- Store lyophilised powder at −20°C immediately after arrival.
- Protect from light and atmospheric moisture; keep vials tightly sealed.
- Once reconstituted, aliquot into working volumes and freeze at −20°C or −80°C.
- Avoid freeze–thaw cycles; use each aliquot once and discard remains.
- Under proper storage, the powder retains integrity for 1–2 years; reconstituted solutions should be used within weeks depending on the storage buffer.
Contrôle qualité et analyses
Each production lot of Semax bulk powder for research undergoes rigorous analytical testing to confirm identity and purity. The primary method for purity assessment is reversed-phase HPLC, which quantifies the target peptide relative to any synthesis-related impurities. Typically a purity threshold of ≥98% is set to ensure batch suitability for sensitive research applications. Liquid chromatography–mass spectrometry (LC–MS) or matrix-assisted laser desorption/ionisation (MALDI–MS) verifies the molecular mass, confirming correct sequence assembly. A comprehensive Certificate of Analysis (CoA) is issued for every batch detailing HPLC chromatograms, mass spectrum, peptide content (often expressed as net peptide percentage), and residual solvents when applicable. These documents are available to researchers, distributors, and procurement departments to support institutional compliance and experimental reproducibility.
Batch Consistency
For long-term studies that span multiple orders, batch-to-batch consistency is paramount. Manufacturers of Semax bulk powder apply stringent controls over raw materials, solid-phase synthesis parameters, and purification protocols. Every batch is tested against a reference standard to confirm peptide content and purity fall within predefined acceptance ranges. Stability-indicating methods are periodically repeated to monitor degradation trends. This systematic approach yields a product line whose physicochemical behaviour remains uniform across production campaigns. Researchers can request archived sample data or comparative CoAs to verify consistency when planning extended experimentation or multi-centre collaboration.
Ordering and Shipping Information
Semax bulk powder for research is available to accredited research institutions, pharmaceutical companies, and authorised distributors. Vials are typically offered in sizes ranging from milligrams to multi-gram quantities, sealed under inert gas and packed with desiccant pouches inside moisture-barrier bags. Shipment occurs at ambient temperature, as lyophilised peptides are generally stable for the duration of transit. Upon receipt, the outer packaging should be inspected for integrity, and the product immediately transferred to −20°C storage. Procurement officers are advised to plan orders to coincide with scheduled experiments, allowing time for customs clearance where international shipping applies. For routine reordering, catalog or batch references should be cited to ensure continuity.
Compliance and Safety Considerations
Material Safety Data Sheets (MSDS) accompany all bulk shipments and outline safe handling practices. Although Semax is a research chemical with no known acute toxicity under standard laboratory conditions, standard personal protective equipment (PPE) such as lab coats, safety glasses, and nitrile gloves should be worn when weighing or reconstituting the powder. Waste disposal must comply with institutional regulations for peptide-based research materials. Semax bulk powder is intended solely for in vitro laboratory research or use in animal models in compliance with applicable ethical guidelines. It is not for human or veterinary use. All research must be conducted by qualified personnel in controlled settings, and any data generated should not be extrapolated to clinical or diagnostic contexts.
Réservé à la recherche. This product is not for use in humans or animals intended for food production. It is not to be used as a drug, food additive, or household item. Laboratory researchers assume full responsibility for compliance with all local, national, and international regulations pertaining to the handling and application of this peptide.
Réservé à la recherche. Ne pas utiliser chez l'homme ni chez les animaux.
